Cancer Metastasis: Biologic Basis and TherapeuticsDavid Lyden, Danny R. Welch, Bethan Psaila Metastasis is responsible for a large burden of morbidity and mortality among cancer patients, and currently few therapies specifically target metastatic disease. Further scientific dissection of the underlying pathways is required to pave the way for new therapeutic targets. This groundbreaking new text comprehensively covers the processes underlying cancer metastasis and the clinical treatment of metastatic disease. Whereas previous volumes have been compendia of laboratory research articles, the internationally renowned authors of this volume have summarized the state-of-the-art research in the metastasis field. A major section covers the cellular and molecular pathways of metastasis and experimental techniques and the systems and models applied in this field. Subsequently, the clinical aspects of the major cancer types are considered, focusing on disease-specific research and therapeutic approaches to metastatic disease. The focus is on novel pathophysiological insights and emerging therapies; future directions for research and unmet clinical needs are also discussed. |
Contents
| 5 | |
| 15 | |
Computational Models | 25 |
Intravital Microscopy to Visualize Invasion and Metastasis | 40 |
GENES | 55 |
The Role of Metastasis Suppressor Genes in Metastasis | 64 |
StromalDerived Factors That Dictate OrganSpecific Metastasis | 77 |
Epigenetics | 85 |
Therapeutic Approaches for Metastatic | 313 |
Gastric Cancer Metastasis | 325 |
Metastatic Pancreatic Cancer | 333 |
Metastasis of Primary Liver Cancer | 344 |
Advances in Management of Metastatic Colorectal Cancer | 356 |
Lung Cancer Metastasis | 369 |
Evaluation and Treatment | 382 |
Bladder Cancer | 395 |
Germline Variation and Other Host Determinants of Metastatic | 96 |
VARIOUS PROPERTIES OF CANCER CELLS | 117 |
Apoptosis Anoikis and Senescence | 131 |
Metastatic Inefficiency and Tumor Dormancy | 148 |
STROMAL CELLSEXTRACELLULAR MATRIX | 155 |
Proteolytic Cascades in Invasion and Metastasis | 167 |
Role of Matrix Metalloproteinases in Tumor Invasion and Metastasis | 183 |
CellDerived Microvesicles and Metastasis | 191 |
SYSTEMIC FACTORS | 199 |
Determinants of OrganSpecific Metastasis | 215 |
Function and Expression of the uPAuPAR System in Cancer Metastasis | 223 |
On the Route to Cancer Metastasis | 237 |
CLINICAL RESEARCH | 255 |
Neuroblastoma | 264 |
Retinoblastoma | 278 |
Primary Brain Tumors and Cerebral Metastases | 282 |
Head and Neck Cancer Metastasis | 294 |
Bone Complications of Myeloma and Lymphoma | 417 |
Breast Metastasis | 425 |
Gynecologic Malignancies | 440 |
Thoughts on Biology and Therapeutics | 456 |
The Biology and Treatment of Metastatic Testicular Cancer | 465 |
Applications of Proteomics to Metastasis Diagnosis and Individualized | 475 |
Critical Issues of Research on Circulating and Disseminated Tumor Cells | 486 |
Molecular Imaging and Metastasis | 516 |
Preserving Bone Health in Malignancy and Complications | 538 |
Role of Platelets and Thrombin in Metastasis | 552 |
THERAPIES | 563 |
Immunotherapy | 587 |
Discovery and Development of Drugs Targeting Tumor Invasion | 600 |
The Role of Radiotherapy in the Treatment of Metastatic Disease | 612 |
Prospects for Clinical Trials of Metastasis Inhibitors | 622 |
Other editions - View all
Cancer Metastasis: Biologic Basis and Therapeutics David Lyden,Danny R. Welch,Bethan Psaila No preview available - 2011 |
Common terms and phrases
activity adhesion adjuvant angiogenesis antibody apoptosis associated bevacizumab biomarkers bladder cancer blood bone marrow brain breast cancer cancer cells cancer metastasis cancer patients cathepsin cell carcinoma cell lines cellular cetuximab chemokine chemotherapy cisplatin Clin Cancer Res Clin Oncol clinical colorectal cancer cytokines detection E-cadherin EGFR epithelial function gene expression genetic growth factor head and neck human imaging increased induced inhibition inhibitors integrin interactions invasion kinase lesions liver lung cancer lymphatic macrophages malignant markers matrix melanoma metas metastasis metastatic metastatic disease mice microenvironment micrometastases MMPs molecular molecules mutations neuroblastoma nodal Oncogene osteoclast ovarian cancer overexpression pancreatic pathway percent Phase primary tumor prognostic progression promote prostate cancer proteases protein receptor recurrence regulation resection response role signaling sorafenib specific stage stem cells stromal suppressor Surg surgical survival target therapeutic therapy tion tissue trastuzumab treatment trial tumor cells tumor growth uPAR VEGF VEGF-C vivo


